A 48-year-old woman on chronic omeprazole therapy for GERD presents with progressive fatigue, glossitis, and paresthesias in the lower limbs. Serum vitamin B12 level is 180 pg/mL (normal 200–900). Which investigation is most appropriate to confirm the mechanism of B12 deficiency in this patient?

## PPI-Induced Vitamin B12 Deficiency ### Clinical Context This patient has: - Chronic PPI use (omeprazole) - Neurological symptoms: glossitis, paresthesias (B12 neuropathy) - Low serum B12 (180 pg/mL) **Key Point:** Long-term PPI use causes **malabsorption-type B12 deficiency** by suppressing gastric acid and intrinsic factor production, impairing food-bound B12 release and absorption. ### Mechanism of PPI-Induced B12 Deficiency 1. **Acid suppression** → reduced pepsin activity → impaired release of B12 from food proteins 2. **Reduced intrinsic factor** → decreased B12 binding and ileal absorption 3. **Altered gastric flora** → reduced bacterial B12 production (minor) ### Investigation of Choice: Serum Methylmalonic Acid (MMA) and Homocysteine **High-Yield:** MMA and homocysteine are **functional markers of B12 deficiency** — they are elevated in **true B12 deficiency** (cobalamin-dependent enzyme dysfunction) but normal in **folate deficiency** or **pseudodeficiency**. **Why This Test?** - **Specificity:** Confirms that low serum B12 reflects **true metabolic B12 deficiency**, not just low serum levels - **Pathophysiology:** - Methylmalonyl-CoA mutase requires B12 → MMA accumulates if B12 is deficient - Methionine synthase requires B12 → homocysteine accumulates if B12 is deficient - **Diagnostic algorithm:** Elevated MMA + elevated homocysteine = **true B12 deficiency** (regardless of cause) ### Differential Diagnosis: Causes of Low Serum B12 | Finding | Pernicious Anemia (Autoimmune) | PPI-Induced Malabsorption | Pseudodeficiency | Folate Deficiency | |---------|--------------------------------|---------------------------|-------------------|-------------------| | **Serum B12** | ↓ | ↓ | ↓ | Normal | | **MMA** | ↑↑ | ↑↑ | Normal | Normal | | **Homocysteine** | ↑↑ | ↑↑ | Normal | ↑ | | **IF Antibody** | Positive | Negative | Negative | Negative | | **Parietal Cell Antibody** | Positive | Negative | Negative | Negative | | **Schilling Test** | Abnormal (corrected with IF) | Abnormal (not corrected with IF) | Normal | Normal | **Mnemonic:** **MMA-HOME** = Methylmalonic acid & HOMocysteine Elevation = true B12 deficiency. ### Why NOT the Other Tests? **Intrinsic Factor & Parietal Cell Antibodies:** - These are **positive in pernicious anemia** (autoimmune gastritis) - In PPI-induced deficiency, antibodies are **negative** — the problem is acid suppression, not autoimmunity - Antibody testing would not confirm the **functional B12 deficiency** in this patient **Schilling Test:** - Historically used but **rarely performed now** (requires radioactive Co-57 B12) - Cannot be done reliably while patient is on PPIs (must stop 1–2 weeks prior) - MMA/homocysteine are more practical, non-radioactive alternatives **Gastric pH & Pepsinogen Ratio:** - These are **supportive findings** (low pepsinogen I/II ratio suggests atrophic gastritis) - They do **not confirm functional B12 deficiency** or distinguish true deficiency from pseudodeficiency ### Clinical Pearl **High-Yield:** PPI-induced B12 deficiency typically occurs after **2–5 years** of continuous use. Risk is higher in: - Elderly patients (reduced dietary B12 intake) - Vegetarians / vegans - Concurrent H. pylori infection or atrophic gastritis **Management:** - **First-line:** Discontinue PPI if possible; switch to H2 blocker or on-demand dosing - **B12 replacement:** Oral cyanocobalamin (if absorption recovers) or IM B12 (if malabsorption persists) [cite:Harrison 21e Ch 297; KD Tripathi 8e Ch 12]